Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme

Journal of Cutaneous Pathology

Volumn 31, Issue 5, 2004, Pages 393-397

  Armstrong, April Wang ^a,b   Fazeli, Amin ^b   Yeh, Shih Wei ^b   Mackool, Bonnie T ^b   Liu, Vincent ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

AGED; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; DERMATITIS; ERYTHEMA MULTIFORME; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LINEAR IMMUNOGLOBULIN A BULLOUS DISEASE; MALE; SKIN BIOPSY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUTOIMMUNE DISEASES; ERYTHEMA MULTIFORME; HUMANS; IMMUNOGLOBULIN A; MALE; SKIN; SKIN DISEASES, VESICULOBULLOUS; VANCOMYCIN;

EID: 1942436304     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2004.00190.x     Document Type: Article

References (12)

1. Nousari HC, Kimyai-Asadi A, Caeiro JP, et al. Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Medicine 1999; 78: 1.
2. Carpenter S, Berg D, Sidhu-Malik N, et al. Vancomycin-associated linear IgA dermatosis. A report of three cases. J Am Acad Dermatol 1992; 26: 45.
3. Kuechele MK, Stegemeir E, Maynard B, et al. Drug-induced linear IgA bullous dermatosis: Report of six cases and review of the literature. J Am Acad Dermatol 1994; 30: 187.
4. Whitworth JM, Thomas I, Peltz SA, et al. Vancomycin-induced linear IgA bullous dermatosis. J Am Acad Dermatol 1996; 34: 890.
5. Dellavalle RP, Burch JM, Tayal S, et al. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. J Am Acad Dermatol 2003; 48: S56.
6. Argenyi ZB, Bergfeld WF, Valenzuela R, et al. Adult linear IgA disease associated with an erythema multiforme-like drug reaction. Cleve Clin J Med 1987; 54: 445.
7. Nousari HC, Costarangos C, Anhalt GJ. Vancomycin-associated linear IgA bullous dermatosis. Ann Intern Med 1998; 129: 507.
8. Wojnarowska F, Allen J, Collier P. Linear IgA, disease. A heterogeneous disease. Dermatology 1994; 189: 52.
9. Paul C, Wolkenstein P, Prost C, et al. Drug-induced linear IgA disease: target antigens are heterogeneous. Br J Dermatol 1997; 136: 406.
10. Zone JJ, Taylor TB, Meyer LJ, Peterson MJ. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol 1998; 110: 207.
11. Marinkovich MP, Taylor TB, Keene DR, et al. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996; 106: 734.
12. Wakelin SH, Allen J, Zhou S, Wojnarowska F. Drug-induced linear IgA disease with autoantibodies to collagen VII. Br J Dermatol 1998; 138: 310.